Response to: Correspondence on "ASAS-EULAR recommendations for the management of axial spondyloarthritis: 2022 update" by Braun et al

Ann Rheum Dis. 2023 Sep;82(9):e206. doi: 10.1136/ard-2023-223937. Epub 2023 Mar 6.
No abstract available

Keywords: Biological Therapy; Epidemiology; Spondylitis, Ankylosing.

Publication types

  • Comment

MeSH terms

  • Axial Spondyloarthritis*
  • Humans
  • Spondylarthritis* / drug therapy
  • Spondylitis, Ankylosing*